dalteparin has been researched along with Lymphoma in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, B | 1 |
| Chan, S | 1 |
| Servaes, S | 1 |
| Zhuang, H | 1 |
| Izzedine, H | 1 |
| Cluzel, P | 1 |
| Deray, G | 1 |
2 other studies available for dalteparin and Lymphoma
| Article | Year |
|---|---|
Multiple FDG-avid injection site granulomas due to lovenox injection.
Topics: Adolescent; Enoxaparin; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Injections; Lymphoma; Mul | 2014 |
Renal radiation-induced arterial stenosis.
Topics: Adult; Angioplasty, Balloon; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hodgkin Disease; Hu | 2007 |